News › Clinical Practice, Industry News, Patient Care

Galderma Receives FDA Approval for Restylane Kysse

May 5, 2020

Galderma has announced that the U.S. Food and Drug Administration (FDA) has approved Restylane Kysse for lip augmentation and the correction of upper perioral rhytids (wrinkles around upper lips) in adults over the age of 21. Restylane Kysse is the first hyaluronic acid (HA) filler specifically indicated for the lips using XpresHAn Technology, globally referred to as the Optimal Balance Technology. Restylane Kysse is proven to last for up to one year with high levels of patient satisfaction for people with lips that have changed due to the aging process or for those seeking natural-looking, fuller lips.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Beyond Either/Or: Building Integrated Treatment Plans with Energy-Based Devices and Injectables
    • FDA Approves Belotero Volume and Belotero Intense
    • Ad IntellX Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • SafeLink Consulting Inc. Launches SafeLink360, Bringing Risk & Compliance Management and Expert Support Together in One Platform
    • TITAN Aesthetic Founder Mary Beth Hagen Transfers Ownership to Carrie Galpin
Advertisement